Combating urinary schistosomiasis: Both metrifonate and praziquantel can be used

Jul 16, 2008

In 2000 the World Health Organization (WHO) stopped recommending metrifonate for treating urinary schistosomiasis because the drug did not appear to be as effective as the treatment of choice, praziquantel. Now a systematic review published in the latest edition of The Cochrane Library indicates that both metrifonate and praziquantel are effective at treating the infection. The team of researchers who carried out this study suggest that metrifonate may be a valid addition to the current one-drug strategy against urinary schistosomiasis.

These findings were reached after considering the data in 24 trials that together involved 6,315 participants.

Urinary schistosomiasis occurs when a tiny worm, a blood fluke (Schistosoma haematobium), penetrates a person's skin while walking or bathing in fresh water contaminated with snails that contain the worm. The fluke lays eggs in the body, and these eggs cause tissue damage that leads to blood in urine and pain on passing urine. If left untreated they can cause serious disease including kidney failure. Estimates indicate that more than 100 million people in African and Eastern Mediterranean regions are infected by the flukes, resulting in considerable social and economic hardships.

Praziquantel requires only one dose and is operationally more convenient, while metrifonate requires three at 14-day intervals. This could be a strong reason for stopping metrifonate use, especially in rural community-based treatment programmes, where it is difficult to give multiple doses. However, the researchers believe that it would be prudent to have more than one drug in use in order to minimise the chance of the organism developing resistance against the only drug, praziquantel.

"Relying only on praziquantel for treating schistosomiasis is a risky strategy as it could encourage the development of drug resistance," says lead researcher Anthony Danso-Appiah, who works at the Liverpool School of Tropical Medicine, Liverpool, UK.

Source: Wiley

Explore further: AMA: avoiding distress in medical school

Related Stories

Europe's bathing waters cleaner, says Brussels

4 hours ago

European beach and river bathing sites have cleaned up their acts, with 95 percent now meeting water quality standards in time for the summer holiday season, the EU said Wednesday.

New antibody insecticide targets malaria mosquito

4 hours ago

Malaria is a cruel and disabling disease that targets victims of all ages. Even now, it is estimated to kill one child every minute. Recent progress in halting the spread of the disease has hinged on the ...

Galaxy's snacking habits revealed

4 hours ago

A team of Australian and Spanish astronomers have caught a greedy galaxy gobbling on its neighbours and leaving crumbs of evidence about its dietary past.

Recommended for you

AMA: avoiding distress in medical school

May 22, 2015

(HealthDay)—Understanding the key drivers underlying medical students' distress can help address the issues and enhance student well-being, according to an article published by the American Medical Association.

European court to rule on right-to-die case

May 21, 2015

Europe's human rights court will on June 5 rule on whether a man in a vegetative state can be taken off life support, a case that has ignited a fierce euthanasia debate in France, a spokesman said Thursday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.